MedifVu Marketing Strategy (need new logo’s) June, 2011.

MedifVu Marketing Strategy

(need new logo’s)

June, 2011

© Medicines Differentiation Analytics LLC, 2011, all rights reserved, PATENT PENDING

Overall Plan – original steps

Key Steps: Create Marketing Materials Determine Pricing Model Buyers – hold face to face Partners – hold face to face Capital Venture – hold face to face

2


Develop Marketing Materials

3

Tasks:

Finalize Name & Logo - Complete Create 3/30/3/30 speech – complete – only to update for recent changes

The MDA Process:Reflects True Differentiation Is Customer-DrivenMonetizes Value

Create Brochure – in process Create Website - done Establish Business Cards – done to be printed Write LES article - TBD

© Medicines Differentiation Analytics LLC, 2011, all rights reserved, PATENT PENDING 4

What Outcomes are We Looking For?

Possible Outcomes:

Sell outright to IT/Consulting Co.License Software to IT/Consulting Co, maintain consulting

rightsSell to one big client and implementGet Capital Funding to create companyUse as consulting buz only

Other Outcomes? Pros & Cons


Determine Pricing Model

5

Tasks:

Identify Options Determine pro’s and con’s of each

Use for Consulting Purposes Only, we hold software and

disguised data

Bio/Pharma Company buys

software and builds data on their own

BPO type partnership with large company

Our InvolvementHigh Low to None

Should we prepare this fo

r each type of

partner/b

uyer/cap venture?

IE: what is

the m

onetary value/expectations?


Buyers -- Hold Face to Face Meetings

6

Tasks:

Prioritize List of Contacts – Complete, see next pages Update 30 minute Materials & Brochure Determine desired outcomes Schedule & Hold initial meetings

Merck KKaSanofi

Build longer term list of prioritized clients


Buyers – Prioritized List

7

Company # of PeopleDepth of

RelationshipDecision Making

Position?Score

Desirable & relavance?

Final Score

Merck Kka1

High High

1 1 1

Merck8

High High

1 2 2

Sanofi Aventis1

High Med

2 1 2

Pfizer4

High High

1 3 3

Genzyme 2 High Low 3 1 3

Astra Zeneca3

Med High2 2 4

Diffusion Pharmaceuticals 1

High High

1 4 4

J&J 2High Low

3 2 6

Merial 2 High Med 2 3 6

Novartis 2 Med Med 4 2 8

Roche Pharma 1 Med Med 4 2 8

MedImmune 1 Med Med 4 2 8

Deleware INBRE 1 High Med 2 4 8

BMS 2 Low Med 5 2 10

Shire Pharma 1 Med Low 5 2 10

Teva Pharma1

Med Low

5 2 10

Opsonics Therapuetics1

Low ?

6 2 12

PTC Therapuetics 1 Low ? 6 2 12

Sandoz1

Med Low5 3 15

Baxter Healthcare1

Low Low6 3 18

Ambrx 1 Low ? 6 3 18

CareFusion1

Low ?6 3 18

Catalent Pharma Solutions1

Low ?

6 3 18

HemoShear 1 Low ? 6 3 18

Mylan Pharma 1 Low ? 6 3 18

Vertex Pharma 1Low Low

6 3 18

George Pompetski (Tax)

Bill Boynton(Proc. Imp)


IT/Consulting Partners -- Hold Face to Face Meetings

8

Tasks:

Prioritize List of potential Partners – complete see next page Finalize 30 minute Materials geared towards them Determine desired outcomes Schedule & Hold meetings

PWCAccentureCongnivant


Partners – Prioritized List

9

IT/Consulting # of PeopleDepth of

Relationship

Decision Making

Position?Score


Final Score

PWC2

high high1 1 1

Accenture4

high high1 2 2

Cognivant2

med high2 1 2

SAS3

high med2 3 6

Thomson Reuters 5 med low 4 1 4

IMS 0low low

6 2 12

Deloitte Recap 0 low low 6 2 12

Medtrack 0 low low 6 2 12

Bio Pharm Insights 0 low low 6 2 12

Ingenix 0 low low 6 2 12

ShareVault 0 low low 6 3 18

SDI - Oncology tracker 0 low low 6 3 18

Clin trials - almac group0

low low6 3 18

Brian Tullly (Tax)


Capital Venture -- Hold Face to Face Meetings

10

Tasks:

Prioritize List of potential Partners – complete see next page Finalize 30 minute Materials geared towards them Determine desired outcomes Schedule & Hold meetings

MPM Capital


Cap Venture – Prioritized List

11

Capital Ventures:

# of People

Depth of Relationship

Decision Making

Position?Score


Final Score

MPM Capital Venters 1

High High1 1 1

Sofinnova Ventures 2

Med High2 1 2

Clarus ventures1

Low High3 1 3

Bill Gates Foundation 1

Med High2 2 4

© Medicines Differentiation Analytics LLC, 2011, all rights reserved, PATENT PENDING 12

Next Steps

Get Logo’s Do we have a preference – buyer, cap venture or partner first? Update general 3/30/3/30 based on recent web materials Prepare Initial Contact with each priority

Clarify desired outcomeModify 3/30/3/30 materials for situation

Schedule meetings Complete Brochure & Bus Cards Strategize with Larry Maisel on cap Ventures Other?

MedifVu Marketing Strategy (need new logo’s) June, 2011.

Documents

Transcript of MedifVu Marketing Strategy (need new logo’s) June, 2011.